CIAM
GOSS icon

Caitong International Asset Management’s Gossamer Bio GOSS Stock Holding History

Caitong International Asset Management’s Portfolio GOSS Stock Details GOSS Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		– Hold
0
– – – 3169
2026
Q1 		– Sell
-339
Closed -$84K – 2776
2025
Q4 		$84K Buy
339
+69
+26% +$15.8K 0.02% 502
2025
Q3 		$56.9K Buy
+270
New +$47.6K 0.04% 283

Other funds holding GOSS

D.E. Shaw & Co
D.E. Shaw & Co New York $210B AUM 57.28% 1-Year Est. Return
6CM
683 Capital Management New York $2.04B AUM 94.26% 1-Year Est. Return
DIG
DeepCurrents Investment Group New York $3.3B AUM 12.57% 1-Year Est. Return
CCM
Context Capital Management Lajolla, California $5.15B AUM 1.28% 1-Year Est. Return
WVP
Worth Venture Partners Fort Lee, New Jersey $44.3M AUM 34.55% 1-Year Est. Return
AQR Capital Management
AQR Capital Management Greenwich, Connecticut $287B AUM 42.33% 1-Year Est. Return
GCP
GSA Capital Partners London, United Kingdom $1.59B AUM 39.81% 1-Year Est. Return
WAM
Wolverine Asset Management Chicago, Illinois $11.4B AUM 5.65% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $72.6B AUM 54.88% 1-Year Est. Return
KCM
Kalehua Capital Management Dallas, Texas $174M AUM

Caitong International Asset Management's GOSS Position: Q2 2026 in Review

Caitong International Asset Management held its Gossamer Bio (GOSS) position steady in Q2 2026 at 0 shares worth $0. The position accounts for ﹤0.01% of the portfolio, ranked #3169.

Caitong International Asset Management first reported a position in GOSS in Q3 2025 and has held it in 2 quarters since. The position peaked at $84K in Q4 2025. 166 funds tracked by Wall St. Rank hold GOSS as of Q2 2026.

  • Caitong International Asset Management held 0 shares of Gossamer Bio worth $0 as of Q2 2026.
  • Caitong International Asset Management left its Gossamer Bio share count unchanged in Q2 2026.
  • Gossamer Bio made up ﹤0.01% of Caitong International Asset Management's portfolio in Q2 2026, its #3169 holding.
  • Caitong International Asset Management first reported a position in Gossamer Bio in Q3 2025 and has held it in 2 quarters since.
  • Caitong International Asset Management's Gossamer Bio position peaked at $84K in Q4 2025.
  • 166 funds tracked by Wall St. Rank held Gossamer Bio as of Q2 2026.

Based on Caitong International Asset Management's 13F filing for Q2 2026, filed 5 Aug 2026.